Adult Immunization Allergy & Immunology Cardiology Dermatology Endocrinology Gastroenterology Infectious Disease Men’s Health Nephrology Neurology Pain Management Pediatric Immunization Pediatrics Psychiatry Pulmonology Rheumatology Screening Women’s Health

Billing and Collections Career Planning Coding and Documentation Concierge Medicine Cybersecurity EHRs Investing Patient Relations Personal Finance Practice Management Remote Patient Monitoring Staffing Technology Telehealth Value-based Care

Unmet Needs in Managing MDD Interpreting Thyroid Function Tests Using Thyroid Lab Tests Testing & Screening to Optimize Men's Health

Nephrology

Latest News

Sotagliflozin in Patients with Type 1 Diabetes and CKD to be Discussed at October FDA AdComm Meeting

By Grace Halsey

October 14th 2024

Lexicon's sotagliflozin is on the October 31 docket for discussion by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee; PDUFA goal date remains set for December 20.

The System Isn’t Working for Americans with Kidney Disease

By Mahesh Krishnan, MD, MPH, MBA

September 5th 2024

Tirzepatide Tied to Lower Risk for Death, Adverse CV and Kidney Outcomes vs GLP-1s: Daily Dose

By Sydney Jennings

August 23rd 2024

Tirzepatide Real-World Benefit Found Greater for CV, Renal Outcomes vs GLP-1 RAs in Adults with T2D

By Grace Halsey

August 12th 2024

Finerenone Phase 3 Data Show Benefit in HFpEF, Promise for New Indication

By Grace Halsey

August 6th 2024

Latest CME Events & Activities

Community Practice Connections: 7th Annual School of Nursing Oncology™

6th Annual Precision Medicine Symposium: An Illustrated Tumor Board

October 18-19, 2024

Bridging the Care Gap in Anemia in CKD: A Comprehensive Guide to Enhancing Patient Care

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?

Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy

7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow

GU Tumor Board®: Real World Strategies to Inform Individualized Care in Renal Cell Carcinoma

Medical Crossfire®: Optimizing Care for Patients With Anemia and Chronic Kidney Disease

18th Annual New York GU Cancers Congress™

March 28-29, 2025

Show Me Your Care Plan!™: Nurses on the Forefront of Patient Care, Communication, and Education in Prostate Cancer

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management

Patient, Provider & Caregiver Connection™: Individualizing Care in Chronic Kidney Disease – Understanding Disparities in Care and the Role of APOL1 Mediated Kidney Disease

Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy

More News

Autosomal Dominant Polycystic Kidney Disease: Studies in Comorbidity

September 6th 2019

Studies on comorbidities seen with CKD reviewed here examine controlled vs uncontrolled gout, psychiatric diagnoses, and screening for intracranial aneurysm.

ADPKD, autosomal dominant polycystic kidney disease, kidney disease

ADPKD Quiz: Questions on Disease Progression

Andrew Bowser

September 5th 2019

The risk for end-stage renal disease in patients with ADPKD is high. What factors increase the risk and how is it best managed? Test yourself.

Autosomal-dominant Polycystic Kidney Disease: 3 Studies in Brief

Andrew D. Bowser

July 7th 2019

Three new studies on ADPKD treatment project long-term impact of tolvaptan; reveal potential in an existing drug class; and, report success in slowing comorbid hepatic disease.

For ADPKD in Children, New Guidelines Speak to Ethical Issues

Andrew D. Bowser

July 3rd 2019

Most children with ADPKD remain asymptomatic, but some manifest early and aggressive disease. Try our 6 questions on the new expert guidance on tricky treatment issues.

Polycystic Kidney Disease: Studies on Obesity, Pain, Screening

Andrew Bowser

May 9th 2019

Find summaries here of 3 recent studies conducted to shed light on difficult issues in the management of autosomal dominant polycystic kidney disease.

Polycystic Kidney Disease, Polycystic Kidney Disease treatment, ADPKD, CKD

Polycystic Kidney Disease: What's Your ADPKD IQ?

Andrew D. Bowser

May 6th 2019

Autosomal dominant polycystic kidney disease is the most common form of polycystic renal disease. Find out what you know about ADPKD with this 7-question quiz on epidemiology, diagnosis, and more.

Chronic Kidney Disease: 7 Questions for Primary Care

Andrew D. Bowser

March 7th 2019

The primary care role in detection, management, and reducing the risk of progression of CKD continues to expand. Test yourself here on basics in each category.